RECENT LICENSE AGREEMENTS (Details Textual) - MaximumMember	6 Months Ended
Jul. 04, 2015 USD ($)
Elis Pharmaceuticals [Member]
License fee received	$ 35,500,000
Khandelwal [Member]
License fee received	$ 2,600,000

Cash received from licensees for license fees during the current period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration